IMV Inc. Stock News

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on IMV (IMV – Research Report) today and set a price

IMV Inc. Announces Fourth Quarter and Full Year 2019 Financial and Operational Results

Two coronavirus vaccine candidates are in the clinics and 42 more are in preclinical studies, according to updated data provided by the World Health Organization on March 20.Three biopharma companies

Fly Intel: Pre-market Movers JNJ ABT SNY PSTV OMI HEXO AXSM MITT

Plus Therapeutics. (NASDAQ:PSTV) +63% in-licenses novel oncology candidates.Bellerophon Therapeutics (NASDAQ:BLPH) +40% as first COVID-19 patient has been treated with the INOpulse inhaled nitric o

IMV Inc. (Nasdaq: IMV) (TSX: IMV), a clinical-stage biopharmaceutical company (the "Company" or "IMV"), today provided updates on the development of DPX-COVID-19, a vaccine candidate against the novel

The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.

IMV to Announce Fourth Quarter and Full Year 2019 Financial and Operational Results and Host Investor Conference Call and Webcast on March 31, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Moderna (MRNA -15.9%) slumps on more than double normal volume on the heels of comments today from FDA Commissioner Stephen Hahn (during the Coronavirus Task Force briefing) that approval of a COVID-1

Midway through trading Wednesday, the Dow traded down 5.99% to 19,965.62 while the NASDAQ fell 4.59% to 6,997.75. The S&P also fell, dropping 5.35% to 2,394.00. Total cases in...

Following the market opening Wednesday, the Dow traded down 4.17% to 20351.87 while the NASDAQ fell 2.96% to 7,117.79. The S&P also fell, dropping 3.85% to 2,431.81. Total...

Micro-cap Canadian biopharma Imv Inc (NASDAQ: IMV) said Wednesday that it is advancing the clinical development of a DPX-based vaccine candidate for the coronavirus, joining a number of biotechs worki

Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N

IMV Inc. Establishes At-the-Market Facility